Verona Pharma PLC ADR Net Asset Quality Index
Verona Pharma PLC ADR net asset quality index. Verona Pharma PLC ADR (VRNA) has a Net Asset Quality Index of 48.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $572.87 Million minus total liabilities of $294.60 Million yields net assets of $278.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is Verona Pharma PLC ADR's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Verona Pharma PLC ADR (2005–2024)
Net asset quality index of Verona Pharma PLC ADR from 2005 to 2024. This chart shows how Verona Pharma PLC ADR's Net Asset Quality Index has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the index stands at 48.6%, representing net assets of $278.27 Million against total assets of $572.87 Million USD. See Verona Pharma PLC ADR shareholders equity for net asset value and shareholders' equity analysis.
Verona Pharma PLC ADR Net Asset Quality Index by Year (2005–2024)
Verona Pharma PLC ADR net asset quality index by year from 2005 to 2024. The table below presents the year-by-year Net Asset Quality Index for Verona Pharma PLC ADR from 2005 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see VRNA market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.1% | $204.56 Million | $474.24 Million | $269.68 Million | ▼ -37.8 pp |
| 2023 | 80.9% | $249.28 Million | $308.12 Million | $58.84 Million | ▼ -7.9 pp |
| 2022 | 88.8% | $230.47 Million | $259.47 Million | $29.00 Million | ▲ +9.5 pp |
| 2021 | 79.3% | $148.00 Million | $186.59 Million | $38.58 Million | ▼ -11.2 pp |
| 2020 | 90.5% | $184.85 Million | $204.21 Million | $19.35 Million | ▲ +15.5 pp |
| 2019 | 75.0% | $44.40 Million | $59.18 Million | $14.78 Million | ▼ -9.7 pp |
| 2018 | 84.7% | $79.86 Million | $94.23 Million | $14.37 Million | ▼ -4.5 pp |
| 2017 | 89.2% | $107.95 Million | $120.96 Million | $13.00 Million | ▲ +14.5 pp |
| 2016 | 74.7% | $42.53 Million | $56.93 Million | $14.40 Million | ▼ -0.8 pp |
| 2015 | 75.5% | $8.28 Million | $10.96 Million | $2.69 Million | ▼ -20.5 pp |
| 2014 | 96.0% | $19.62 Million | $20.43 Million | $816.08K | ▲ +15.1 pp |
| 2013 | 80.9% | $3.41 Million | $4.22 Million | $806.89K | ▼ -12.0 pp |
| 2012 | 92.9% | $4.21 Million | $4.53 Million | $322.11K | ▼ -3.4 pp |
| 2011 | 96.3% | $6.29 Million | $6.53 Million | $242.21K | ▲ +1.9 pp |
| 2010 | 94.4% | $5.33 Million | $5.64 Million | $317.94K | ▲ +0.4 pp |
| 2009 | 94.0% | $7.25 Million | $7.71 Million | $464.08K | ▼ -4.0 pp |
| 2008 | 97.9% | $5.85 Million | $5.97 Million | $123.01K | ▲ +3.1 pp |
| 2007 | 94.8% | $5.73 Million | $6.04 Million | $311.35K | ▼ -3.5 pp |
| 2006 | 98.3% | $7.64 Million | $7.77 Million | $129.31K | ▼ -0.5 pp |
| 2005 | 98.8% | $1.68 Million | $1.71 Million | $20.65K | — |